Brickell Biotech, Inc. Made Headway

Tue, Jan 05, 2021 at 05:32 PM
Brickell Biotech, Inc. Made Headway

Brickell Biotech, Inc. (BBI:NASDAQ) soared at $1.22, a gain of 48.5%. The stock got featured on our News Catalysts scanner on Sat 19 Dec 20 at 12:20 AM in the 'BIOTECH' category. From Mon 21 Dec 20, the stock recorded 62.50% Up Days and 66.67% Green Days

The stock spiked on Mon 28 Dec 20 at $0.99 with a volume of 8M+, and its share price has been moving sideways in recent weeks.

About Brickell Biotech, Inc. (BBI:NASDAQ)

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.